MTHFR and acute myeloid leukemia: Thirteen studies including 1838 cases and 5318 controls had examined the association of MTHFR C677T polymorphism with AML risk, and 9 studies with a total of 1335 patients and 4295 controls investigated the association between MTHFR A1298C polymorphism and AML risk.